Humoral Response to SARS-CoV-2-Vaccination with BNT162b2 (Pfizer-BioNTech) in Patients on Hemodialysis

mRNA-based SARS-CoV-2 vaccines offer a preventive strategy against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infections that is of interest in the care of patients on hemodialysis (HDP). We measured humoral immune responses in 72 HDP after standard vaccination with two doses of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Jahn, Michael, Korth, Johannes, Dorsch, Oliver, Anastasiou, Olympia Evdoxia, Sorge-Hädicke, Burkhard, Tyczynski, Bartosz, Gäckler, Anja, Witzke, Oliver, Dittmer, Ulf, Dolff, Sebastian, Wilde, Benjamin, Kribben, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8070660/
https://www.ncbi.nlm.nih.gov/pubmed/33918085
http://dx.doi.org/10.3390/vaccines9040360

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8070660/
https://www.ncbi.nlm.nih.gov/pubmed/33918085
http://dx.doi.org/10.3390/vaccines9040360

Ejemplares similares